ACGT Grantees Achieve Milestones in Lymphyblastic Leukemia Research and Treatment

  • | Jan 15 2015 |

Lymphyblastic leukemia is a destructive, painful blood cancer that progresses quickly and can be fatal within months if left untreated. And while treatments such as chemotherapy are currently commonly used, many patients suffer relapse, lowering the disease’s overall cure rate to between 30 and 40 percent. But the genetic modification of T-lymphocytes is now emerging […]

Read More